Stocktoria
Tempest Therapeutics, Inc. TPST
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-10-04
Tempest Therapeutics, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | — | — | — | — | -28585.1% | -12406.1% |
| Net margin | — | — | — | — | — | — | — | — | -28670.5% | -12597.2% |
| FCF margin | — | — | — | — | — | — | — | — | -6896.3% | -9849.9% |
| Return on assets | -155.1% | -100.9% | -57.1% | -77.5% | -38.6% | -84.0% | -59.4% | -32.3% | -426.9% | -67.1% |
| Return on equity | -393.9% | -218.8% | -110.2% | -197.2% | -78.4% | 27.9% | -74.4% | -37.2% | 64.7% | -76.0% |
| Debt / equity | — | 0.33× | 0.39× | 0.57× | 0.42× | -0.00× | 0.00× | 0.01× | -0.00× | — |
| Current ratio | 2.50 | 2.21 | 4.29 | 4.53 | 3.44 | 6.15 | 5.68 | 8.50 | 4.82 | 8.82 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.